Riddhi Siddhi Gluco Biols Ltd
06 Nov 2026 12:00 AM
Riddhi Siddhi Gluco Biols Ltd consolidated sales down 26.02% on year in Q3FY2026, net profit surged by 127.57%,
Riddhi Siddhi Gluco Biols Ltd share price gained 3.25% to Rs 692.7 after the company`s net profit soared by 127.57% to Rs 6.85 crore, while revenue from operations dropped sharply 26.02% to Rs 66.49 crore in Q3FY26 over Q2FY26.
The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 62485.26 crore, heading higher 12.26%. It has improved by 7.07% over last one week and edged lower by 3.52% in last one month while the market capitalization of Riddhi Siddhi Gluco Biols Ltd has marginally improved by 0.39% and 12.98% in the same period respectively.
Profit before tax (PBT) of Riddhi Siddhi Gluco Biols Ltd stood at Rs 8.83 crore in Q3 FY26, tanking 40.78% year-on-year, and expanding by 76.95% quarter-on-quarter. EBITDA came in at Rs 10 crore, plunging by 51.70% YoY and crashing by 49.41% sequentially.
Total expenses saw a steep drop of 31.66% to Rs 64.81 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 5.33 crore, falling by 16.46% YoY, while employee benefits expense was at Rs 3.15 crore, jumping 34.04% YoY.
For the TTM ended FY26, revenue from operations jumped by 74.04% to Rs 235.84 crore, while net profit witnessed a sharp fall of 67.66% to Rs 20.39 crore, compared to previous TTM. EBITDA tanked by 8707% to Rs 80.9 crore, and PBT plunged by 57.27% to Rs 30.54 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 9.24 crore in FY26, as against Rs 28.3 crore in FY25.
Riddhi Siddhi Gluco Biols Ltd rallied 30.75% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 4.80% during the same period.
Riddhi Siddhi Gluco Biols Ltd
05 Nov 2026 12:00 AM
Riddhi Siddhi Gluco Biols Ltd consolidated sales down 26.02% on year in Q3FY2026, net profit soared by 127.57%,
Riddhi Siddhi Gluco Biols Ltd share price gained 0.88% to Rs 670.9 after the company`s net profit surged by 127.57% to Rs 6.85 crore, while revenue from operations plunged by 26.02% to Rs 66.49 crore in Q3FY26 over Q2FY26.
The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 62485.26 crore, declining 3.22%. It has marginally improved by 2.28% over last one week and softened by 2.62% in last one month while the market capitalization of Riddhi Siddhi Gluco Biols Ltd has slipped by 3.87% and 15.72% in the same period respectively.
Profit before tax (PBT) of Riddhi Siddhi Gluco Biols Ltd stood at Rs 8.83 crore in Q3 FY26, crashing by 40.78% year-on-year, and rallying 76.95% quarter-on-quarter. EBITDA came in at Rs 10 crore, tanking 51.70% YoY and nosediving by 49.41% sequentially.
Total expenses tumbled by 31.66% to Rs 64.81 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 5.33 crore, falling by 16.46% YoY, while employee benefits expense was at Rs 3.15 crore, soaring 34.04% YoY.
For the TTM ended FY26, revenue from operations surged 74.04% to Rs 235.84 crore, while net profit tanked by 67.66% to Rs 20.39 crore, compared to previous TTM. EBITDA saw a sharp decline of 8707% to Rs 80.9 crore, and PBT collapsed by 57.27% to Rs 30.54 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 9.24 crore in FY26, as against Rs 28.3 crore in FY25.
Riddhi Siddhi Gluco Biols Ltd rallied 20.31% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 7.38% during the same period.
Riddhi Siddhi Gluco Biols Ltd
31 Aug 2026 12:00 AM
Riddhi Siddhi Gluco Biols appoints Taral Shah as director for five years,
Riddhi Siddhi Gluco Biols Limited announced the appointment of Taral Shah as an Additional Director in the category of Non-Executive Independent Director for a term of five years, subject to shareholder approval at the company’s Annual General Meeting, and the re-appointment of M/s. Batliboi & Purohit as the company’s Statutory Auditors for a second term of five consecutive financial years from fiscal year 2026-27 to fiscal year 2030-31, also pending shareholder approval. The company’s board also approved the Directors’ Report for the financial year ended March 31, 2026, and the notice for the 35th Annual General Meeting scheduled for September 25, 2026, with September 18, 2026, set as the record date for dividend eligibility and voting.
Riddhi Siddhi Gluco Biols Ltd
31 Aug 2026 12:00 AM
Riddhi Siddhi Gluco Biols appoints Taral Shah, re-appoints auditors for five years,
Riddhi Siddhi Gluco Biols Limited announced the appointment of Taral Shah as an Additional Director in the category of Non-Executive Independent Director for a term of five years, subject to shareholder approval at the company’s Annual General Meeting, and the re-appointment of M/s. Batliboi & Purohit as Statutory Auditors for a second term of five consecutive financial years from fiscal year 2026-27 to fiscal year 2030-31, also pending shareholder approval. The company’s board also approved the Directors’ Report for the financial year ended March 31, 2026, and the notice for the 35th Annual General Meeting scheduled for September 25, 2026, with September 18, 2026, set as the record date for dividend eligibility and voting.
Riddhi Siddhi Gluco Biols Ltd
13 Aug 2026 12:00 AM
Riddhi Siddhi Gluco Biols Ltd consolidated sales up 893.04% on year in Q2FY2026,
Riddhi Siddhi Gluco Biols Ltd share price ticked higher by 1.53% to Rs 764.1 after the company`s net profit tanked by 109.19% to Rs 3.01 crore, while revenue from operations increased sharply by 893.04% to Rs 89.87 crore in Q2FY26 over Q1FY26.
The market capitalization of Trading & Distributors industry group stocks on BSE stood at Rs 49691.37 crore, improving 13.39%. It has eased by 1.11% over last one week and spiked sharply by 24.51% in last one month while the market capitalization of Riddhi Siddhi Gluco Biols Ltd has slipped by 2.04% and 12.87% in the same period respectively.
Profit before tax (PBT) of Riddhi Siddhi Gluco Biols Ltd stood at Rs 4.99 crore in Q2 FY26, tumbling by 63.23% year-on-year, and crashing by 115.91% quarter-on-quarter. EBITDA came in at Rs 20 crore, declining 8.31% YoY and gaining 3.10% sequentially.
Total expenses witnessed a sharp rise of 395.20% to Rs 94.83 crore in Q2FY26 over Q2FY25. During the quarter, cost of materials consumed stood at Rs 6.38 crore, surging by 34.60% YoY, while employee benefits expense was at Rs 2.35 crore, soaring 12.98% YoY.
For the TTM ended FY26, revenue from operations plunged by 49.43% to Rs 135.51 crore, while net profit improved by 10.25% to Rs 63.05 crore, compared to previous TTM. EBITDA saw a sharp decline of 8078% to Rs 85.78 crore, and PBT improved 10.46% to Rs 71.48 crore compared to previous TTM.
The company`s consolidated net cash flow from operating activities stood at Rs 28.3 crore in FY26, as against Rs 8.91 crore in FY25.
Riddhi Siddhi Gluco Biols Ltd rallied 46.83% in last one year, significantly outperforming the benchmark BSE Sensex which has slipped by 2.83% during the same period.
Subscribe for our
newsletter
newsletter
HSL Mobile App